The never ending barrage of television advertising for Taltz, Xeljanz, Otezla, Harvoni, Eliquis and Non-24 all share a common feature – outrageous cost. For a cash paying patient the cost of some of these drugs exceeds $50,000. Drug companies provide co-pay cards not out of kindness, but rather as a ruse to pass the major costs to the insurance companies. Relatively few individuals could afford to purchase the drugs for a traditional co-pay of 20% or $10,000.00. Furthering this peculiarity patients covered by governmental insurance including Medicare and Tricare may not use co-pay cards. When purchased abroad, drugs are considerably less costly.
